Infliximab therapy for moderately severe Crohn’s disease and ulcerative colitis: a retrospective comparison over 6 years

References

• XavierRJPodolskyDKUnraveling the pathogenesis of inflammatory bowl diseaseNature2007448715242743417653185
   PubMed Web of Science ®Google Scholar
• ShiDDasJDasGInflammatory bowel disease requires the interplay between innate and adaptive immune signalsCell Res2006161707416467877
   PubMed Web of Science ®Google Scholar
• FussIJHellerFBoirivantMNonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitisJ Clin Invest2004113101490149715146247
   PubMed Web of Science ®Google Scholar
• LakatosLImmunology of inflammatory bowel diseasesActa Physiol Hung200087435537211732889
   PubMedGoogle Scholar
• TsukadaYNakamuraTIimuraMCytokine profile in colonic mucosa of ulcerative colitis correlates with diseases activity and response to granulocytopharesisAm J Gastroenterol200297112820282812425554
   PubMed Web of Science ®Google Scholar
• MurchSHLamkinVASavageMOSerum concentrations of tumor necrosis factor alpha in childhood chronic inflammatory bowel diseaseGut19913289139171885073
   PubMed Web of Science ®Google Scholar
• MurchSHBraeggerCPWalker-SmithJAMacDonaldTTLocation of tumor necrosis factor α by immunohistochemistry in chronic inflammatory bowel diseaseGut19933412170517098031350
   PubMed Web of Science ®Google Scholar
• BraeggerCPNichollsSMurchSHTumor necrosis factor alpha in stool as a marker of intestinal inflammationLancet1992339878589911345871
   PubMed Web of Science ®Google Scholar
• ProbertCSHearingSDSchreiberSInfliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomized controlled trialGut2003527998100212801957
   PubMed Web of Science ®Google Scholar
• JakobovitsSLJewellDPTravisSPLInfliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006Aliment Pharmcol Ther200725910551060
   PubMed Web of Science ®Google Scholar
• SandsBETremaineWJSandbornWJInfliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot studyInflamm Bowel Dis200172838811383595
   PubMed Web of Science ®Google Scholar
• OschenskuhnTSackmannMGokeBInfliximab for acute, not steroid refractory ulcerative colitis: a randomized pilot studyEur J Gastroenterol Hepatol200416111167117115489577
   PubMed Web of Science ®Google Scholar
• GisbertJPGonzalez-LamaYMateJSystematic review: infliximab therapy in ulcerative colitisAliment Pharmacol Ther2006251193717229218
   PubMed Web of Science ®Google Scholar
• HanauerSBFeaganBFLichtensteinGRMaintenance infliximab for Crohn’s disease: the ACCENT I randomized trialLancet200235993171541154912047962
   PubMed Web of Science ®Google Scholar
• SandsBEAndersonFHBernsteinCNInfliximab maintenance therapy for fistulizing Crohn’s diseaseN Engl J Med2004350987688514985485
   PubMed Web of Science ®Google Scholar
• RutgeertsPSandbornWJFeaganBFInfliximab for induction and maintenance therapy for ulcerative colitisN Engl J Med2005353232462247616339095
   PubMed Web of Science ®Google Scholar
• Lennard-JonesJEClassification of inflammatory bowel diseaseScand J Gastroenterol Suppl1989170262617184
   PubMedGoogle Scholar
• RudolphSJWeinbergDLMcCabeRPLong-term durability of Crohn’s disease treatment with infliximabDig Dis Sci20085341033104117934827
   PubMed Web of Science ®Google Scholar
• LichtensteinGRDiamondRHWagnerAInfliximab administration as a 3-dose induction followed by scheduled maintenance therapy in IBD: comparable clinical outcomes with or without concomitant immunomodulatorsGastroenterology20071325A146
   Google Scholar
• FeaganBMcDonaldJWPanaccioneRA randomized trial of methotrexate in combination with infliximab for the treatment of Crohn’s diseaseGastroenterology20081351294295
   Google Scholar
• ColombelJFSandbornWJReinishHInfliximab, azathioprine or combination therapy for Crohn’s diseaseN Engl J Med2010362151383139520393175
   PubMed Web of Science ®Google Scholar
• SchnitzlerFFidderHFerranteMLong-term outcome of treatment with infliximab in 614 Crohn’s disease patients: results from a single centre cohortGut200958449250018832518
   PubMed Web of Science ®Google Scholar
• SandsBEBlankMAPatelKvan DeventerSJLong-term treatmnet of rectovaginal fistulas in Crohn’s disease: response to infliximab in the ACCENT II studyClin Gastroenterol Hepatol200421091292015476155
   PubMed Web of Science ®Google Scholar
• RutgeertsPFeaganBGLichtensteinGRComparison of scheduled and episodic treatment strategies of infliximab in Crohn’s diseaseGastroenterology2004126240241314762776
   PubMed Web of Science ®Google Scholar
• JarnerotGHertervigEFriis-LibyIInfliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled studyGastroenterology200512871805181115940615
   PubMed Web of Science ®Google Scholar
• LeesCDHeysDHoGTA retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitisAliment Pharmacol Ther200726341141917635376
   PubMed Web of Science ®Google Scholar
• CaspersenSElkjaerMRiisLInfliximab for inflammatory bowel disease in Denmark 1999–2005: Clinical outcome and follow-up evaluation of malignancy and mortalityClin Gastroenterol Hepatol20086111212121718848503
   PubMed Web of Science ®Google Scholar
• PoupardinCLemannMGendreJPEfficacy of infliximab in Crohn’s disease. Result of a retrospective multicenter study with a 15-month follow-upGastroenterol Clin Biol200630224725216565658
   PubMedGoogle Scholar
• TeshimaCWThompsonADhanoaLLong- term response rates to infliximab therapy for Crohn’s disease in an outpatient cohortCan J Gastroenterol200923534835219440565
   PubMed Web of Science ®Google Scholar
• FerranteMVermeireSKonstantinatosHPredictors of early response to infliximab in patients with ulcerative colitisInflamm Bowel Dis200713212312817206703
   PubMed Web of Science ®Google Scholar
• StocchiLPembertonJHPouch and pouchitisGastroenterol Clin North Am200130122324111394032
   PubMed Web of Science ®Google Scholar
• ViscidoAHabibFIKohnAInfliximab in refractory pouchitis complicated by fistulae following ileo-anal pouch for ulcerative colitisAliment Phamacol Ther2003171012631271
   Web of Science ®Google Scholar